Format
Sort by

Send to

Choose Destination

Selected items

Items: 4

1.

Use of (alternative) coreceptors for HIV entry.

Pollakis G, Paxton WA.

Curr Opin HIV AIDS. 2012 Sep;7(5):440-9. doi: 10.1097/COH.0b013e328356e9f3. Review.

PMID:
22842622
2.

Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1.

Tscherning-Casper C, Vödrös D, Menu E, Aperia K, Fredriksson R, Dolcini G, Chaouat G, Barré-Sinoussi F, Albert J, Fenyö EM.

J Acquir Immune Defic Syndr. 2000 May 1;24(1):1-9.

PMID:
10877489
3.

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA.

J Virol. 2000 Jan;74(1):184-92.

4.

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors.

Hoffman TL, Stephens EB, Narayan O, Doms RW.

Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11360-5.

Supplemental Content

Support Center